Biotech leaders campaign for Pazdur; Takeda to lay off 4,500 workers

A coalition of biotech executives and investors is advocating for Rick Pazdur to become the next FDA commissioner, highlighting his influence in the industry. Meanwhile, Takeda has announced plans to lay off 4,500 employees as part of its restructuring efforts, and Alumis is discontinuing a previously promising immune drug.